Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department
Academic Emergency Medicine · 2024
DOI: 10.1111/acem.14773 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Academic Emergency Medicine, 2024. Verfasst von Rachel S Wightman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Emergency Service, Hospital, Vomiting, Cannabinoids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Objectives
Cannabinoid hyperemesis syndrome (CHS) is a clinical condition of cyclic vomiting, nausea, and abdominal pain associated with chronic cannabis use. Despite increased recognition of CHS, there are limited details on cannabis use practices and symptoms over time. Understanding what happens in the period surrounding the emergency department (ED) visit, including any changes in symptoms and cannabis use practices following the visit, can help inform the development of patient‐centered interventions around cannabis use disorder for patients with CHS.
Methods
A prospective observational cohort ( n = 39) of patients with suspected CHS recruited from the ED at the time of a symptomatic cyclic vomiting episode was followed for 3 months. Disease progression, cannabis use practices, and health care utilization were monitored.
Results
Participants reported high rates of persistent CHS symptoms (abdominal pain, nausea, or cyclic vomiting) in the 2‐week period immediately following an ED visit with a median duration of 7 days. Cannabis use frequency and quantity were reduced immediately after the ED visit, but most participants returned to pre‐ED visit cannabis use patterns within a few days. Recurrent ED visits for cyclic vomiting were reported by 25% of participants who completed follow‐up during the 3‐month follow‐up period.
Conclusions
Participants continued to have ongoing symptoms after the ED visit, but most managed symptoms on their own and did not return to the ED. Longitudinal studies beyond 3 months are needed to better understand the clinical course of patients with suspected CHS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
- Center for Alcohol and Addiction Studies, School of Public Health, Brown University, Providence, Rhode Island, USA.
- Providence VA Medical Center, Providence, Rhode Island, USA.
- Brown Emergency Medicine, Providence, Rhode Island, USA.
- Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island, USA.
ORCID-Profile: Rachel S Wightman
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Wightman, R. S., Metrik, J., Lin, T. R., Collins, A. B., & Beaudoin, F. L. (2024). Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department. Academic Emergency Medicine. https://doi.org/10.1111/acem.14773
Vancouver
Wightman RS, Metrik J, Lin TR, Collins AB, Beaudoin FL. Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department. Academic Emergency Medicine. 2024. doi:10.1111/acem.14773
BibTeX
@article{Wightman2024,
author = {Wightman, Rachel S and Metrik, Jane and Lin, Timmy R and Collins, Alexandra B and Beaudoin, Francesca L},
title = {Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department},
journal = {Academic Emergency Medicine},
year = {2024},
doi = {10.1111/acem.14773}
}
EUVIMED